Navigation Links
Sensations Generated By Cocaine And Methamphetamine Abuse Are Not Same.

Investigators from UCLA had found that the there is a marked difference between the sensations generated by cocaine and methamphetamine use in onset, pattern and duration of their “highs”. //

The study shows that subjective, or self-reported, responses to cocaine peak and decline more rapidly than those of methamphetamine. Cardiovascular responses to the two stimulants are similar at onset but responses to cocaine decline more rapidly.

The study was published in the journal Pharmacology, Biochemistry and Behavior.

Researchers said that these differences help explain patterns of use by addicts. Methamphetamine users, for instance, report using the drug daily throughout each day, while cocaine users typically engage in binges that occur most often in the evening.

In addition, the study results may impact development of medication treatments for addiction to these two very different stimulants.

The study examined the onset, pattern and duration of the response to cocaine in 14 cocaine dependent volunteers and the response to methamphetamine in 11 methamphetamine dependent volunteers. None of the volunteers were seeking treatment.

Study volunteers reported subjective effects using a sliding rating scale ranging from 0, or “no drug effect,” to 100, “most drug effect ever.” Ratings were obtained just prior to administration of the drug and at regular intervals for 30 minutes following administration.

Heart rate and blood pressures were assessed using an automated device just prior to administration of the drug and at regular intervals for 60 minutes following administration.

Source: Newwise
'"/>




Page: 1

Related medicine news :

1. Visual Awareness Is Generated At the Back Of The Brain
2. Medications to Prevent Relapse to Cocaine Use
3. Ritalin May Lower Cocaine Abuse
4. Lethal Heart Condition linked To Cocaine Use
5. Cocaine may cause aneurysms for the coronart artery
6. Regular Use Of Cocaine Can Impair Brain Functions
7. Brain of Cocaine Addicts Smaller In Size
8. Cocaine Kates Lover Wants to Kick his Drug Habit
9. Cocaine Acts As Suppressant Not Stimulant In Genetically Altered Mice
10. One Nigerian Cocaine Pedellar Nabbed
11. UN Sounds Alarm Over Rising Cocaine Consumption In Europe
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ORLEANS, La. (PRWEB) , ... July 21, 2017 ... ... to allow 4th-year medical students improve their chances of acceptance to a residency ... for those who have earned degrees outside the U.S. , According to data ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital ... adjustable beds used in such facilities are specially designed to accommodate patients with a ... , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, ...
(Date:7/20/2017)... MD (PRWEB) , ... July 20, 2017 , ... ... company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary ... million. , Proceeds will be used to complete regulatory submissions and fund final ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... July 11, 2017  Bayer has awarded grants totaling more ... part of its prestigious Bayer Hemophilia Awards Program (BHAP). Four ... Philadelphia and Uniformed Services University of the ... the winners. Grant recipients were announced last night during a ... 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
Breaking Medicine Technology: